|Bid||491.80 x 0|
|Ask||492.60 x 0|
|Day's range||491.20 - 539.00|
|52-week range||350.40 - 1,069.00|
|Beta (5Y monthly)||0.82|
|PE ratio (TTM)||47.60|
|Earnings date||25 Feb 2020|
|Forward dividend & yield||0.07 (1.34%)|
|Ex-dividend date||19 Mar 2020|
|1y target est||1,259.67|
Headline figures up, share price down. Why I’m cautious about this stock even though it looks attractive at first glance.The post Why I’m watching this fast-growing pharmaceutical stock appeared first on The Motley Fool UK.
The Clinigen (LON:CLIN) share price has risen by 3.92% over the past month and it’s currently trading at 966.5p. For investors considering whether to buy, hold8230;
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). To keep it...
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
While small-cap stocks, such as Clinigen Group Plc (LON:CLIN) with its market cap of UK£1.3b, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downt...